Dr. Babinchak is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
190 Pembrooke Cir
Suite 101
Phoenixville, PA 19460Phone+1 610-415-9486Fax+1 610-415-9486
Education & Training
Ohio State University HospitalFellowship, Infectious Disease, 1987 - 1989
Allegheny Health Network Medical Education Consortium (AGH)Residency, Internal Medicine, 1984 - 1987
Northeast Ohio Medical UniversityClass of 1984
Certifications & Licensure
OH State Medical License 1988 - 2025
PA State Medical License 1985 - 2024- American Board of Internal Medicine Internal Medicine
Clinical Trials
- Safety and Pharmacokinetics of UV-4B Solution Administered Orally as Multiple Ascending Doses to Healthy Subjects Start of enrollment: 2016 May 27
Publications & Presentations
PubMed
- 281 citationsThe Efficacy and Safety of Tigecycline for the Treatment of Complicated Intra-Abdominal Infections: Analysis of Pooled Clinical Trial DataTimothy Babinchak, Evelyn J. Ellis-Grosse, Nathalie Dartois, Gilbert M. Rose, Evan Loh
Clinical Infectious Diseases. 2005-09-01 - 134 citationsTigecycline: an update.Gary E. Stein, Timothy Babinchak
Diagnostic Microbiology and Infectious Disease. 2013-04-01 - 344 citationsA Randomized and Blinded Multicenter Trial of High-Dose Fluconazole plus Placebo versus Fluconazole plus Amphotericin B as Therapy for Candidemia and Its Consequences ...John H. Rex, Peter G. Pappas, Adolf W. Karchmer, Jack D. Sobel, John E. Edwards
Clinical Infectious Diseases. 2003-05-15
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
